News | June 22, 2009

PET Core Laboratory Plays Critical Role in Insuring Reliable Research Results

June 23, 2009 - The positron emission tomography (PET) core laboratory of the American College of Radiology Clinical Research Center serves a critical role ensuring images and image data from PET scanners used in multicenter clinical trial research meet acceptable standards according to a paper published online June 12 in the Journal of Nuclear Medicine.

This finding was based on a review of the PET scanner qualification program of the American College of Radiology Imaging Network (ACRIN) and reported by the PET core laboratory team of physicists, nuclear medicine physicians and technologists supporting the program.

“Information obtained from PET imaging has increasingly demonstrated its promising role as a non-invasive biomarker for assessing disease status. The goal of the PET qualification program is to insure we are obtaining reliable quantitative and qualitative data across all of the centers participating in PET clinical research,” states lead author Joshua Scheuermann, MS, a clinical physicist at the University of Pennsylvania.

In the past three years, ACRIN has activated a number of clinical trials with PET imaging endpoints and several more are poised to activate in the near future. The PET qualification program requires sites intending to participate in these multi-center trials to demonstrate the scanner to be used in the research protocol meets acceptable calibration standards for obtaining the standardized uptake value (SUV) and production of high quality images. “In the past several years, ACRIN has significantly expanded its PET research, and we are excited about future research projects that will evaluate novel PET radiopharmaceuticals,” says Anthony Levering, RT(R)(CT)(MR),CIIP, an assistant director of the core laboratory. “The PET qualification program provides a high level of confidence regarding the consistent handling of data.”

The authors reviewed data on the qualification of 101 PET scanners for which complete qualification data were available. They reported that, in total, of the 101 scanners to apply for PET qualification from June 2005 through June 2008, 36 sites passed the qualification review with no intervention, 57 sites passed with some type of intervention and eight sites failed and opted not to continue with the qualification process.

“The PET scanner qualification process is rigorous and requires considerable site commitment. Having qualified nearly 170 PET scanners for ACRIN research participation, it was important to evaluate the program to ensure it was making a significant difference in the quality of data collected. These results highlight the importance of a central review of a site’s data and images before data accrued on a PET scanner are used in a multi-center trial,” comments PET core laboratory medical director Barry Siegel, M.D., from Mallinckrodt Institute of Radiology at Washington University School of Medicine.

The PET core laboratory is a key component of the Diagnostic Imaging and Radiation Oncology Core Laboratory of the ACR’s Clinical Research Center located in Philadelphia. The laboratory services the center’s four research entities: ACRIN, the Radiation Therapy Oncology Group, Quality Research in Radiation Oncology, and the ACR Image Metrix.

For more information:,,, and

Related Content

PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...
Abnormal Protein Concentrations Found in Brains of Military Personnel With Suspected CTE

Researchers are using the tracer, which is injected into a patient, then seen with a PET scan, to see if it is possible to diagnose chronic traumatic encephalopathy in living patients. In this image, warmer colors indicate a higher concentration of the tracer, which binds to abnormal proteins in the brain. Credit UCLA Health.

News | PET Imaging | August 24, 2018
August 24, 2018 — In a small study of
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
Novel PET Imaging Method Could Track and Guide Type 1 Diabetes Therapy
News | PET Imaging | August 03, 2018
Researchers have discovered a new nuclear medicine test that could improve care of patients with type 1 diabetes. The...
Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
SNMMI Image of the Year Highlights Theranostic Approach for Advanced Prostate Cancer

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.

68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.

News | PET Imaging | June 29, 2018
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to...
MILabs Introduces Futuristic PET Capabilities on New VECTor6 System
Technology | PET Imaging | June 28, 2018
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia,...
Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
News | PET Imaging | June 25, 2018
IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
Overlay Init